Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritis

INTRODUCTION: Antibodies against mutated citrullinated vimentin (AMCV) represent a useful diagnostic marker with correlation to disease activity in patients with rheumatoid arthritis (RA). Since seropositivity for citrullinated autoantibodies was predictive for response to B-cell depleting therapy (...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindenberg, Luisa, Spengler, Lydia, Bang, Holger, Dorner, Thomas, Maslyanskiy, Aleksej L, Lapin, Sergey V, Ilivanova, Elena I, Martinez-Gamboa, Lorena, Bastian, Hans, Wittenborn, Esther, Egerer, Karl, Burmester, Gerd-R, Feist, Eugen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535682/
https://www.ncbi.nlm.nih.gov/pubmed/26268352
http://dx.doi.org/10.1186/s13075-015-0717-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535682/
https://www.ncbi.nlm.nih.gov/pubmed/26268352
http://dx.doi.org/10.1186/s13075-015-0717-z

Ejemplares similares